On December 7, 2018, AstraZeneca Pharma India and Abbott Healthcare had entered into a distribution agreement for the distribution of Dapagliflozin.from Top India News- News18.com https://ift.tt/3uuOuPe
via IFTTT
Friday, 28 May 2021
AstraZeneca Pharma, Abbott Healthcare Terminate Distribution Agreements for Diabetes Drug in India
On December 7, 2018, AstraZeneca Pharma India and Abbott Healthcare had entered into a distribution agreement for the distribution of Dapagliflozin.from Top India News- News18.com https://ift.tt/3uuOuPe
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment